Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

SHE/000915 stock hub

SHE/000915 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SHE/000915is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

6.8B

Shenzhen Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SHE/000915

In the news

Latest news · SHE/000915

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E11.3

P25 17.1P50 24.2P75 37.8

Trailing P/E12.7

P25 23.5P50 41.3P75 83.2

ROE20.2

P25 -0.9P50 4.1P75 8.8

ROIC73.6

P25 -0.5P50 5P75 11.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SHE/000915 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

236

Groups with data

Currency

CNY

Showing 236 of 236 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	CN
Employees	1,759
Employees Change	-4%
Employees Change Percent	-0.23
Enterprise value	CNY 5B
Exchange	Shenzhen Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	CNE000000Z28
Last refreshed	2026-05-10
Market cap	CNY 6.8B
Price	CNY 28.96
Price currency	CNY
Rev Per Employee	1,150,860.49x
Sector	Healthcare
Sic	2834
Symbol	she/000915
Website	https://www.sd-wit.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	6.83%
EV Earnings	10.82x
EV/EBIT	4.26x
EV/EBITDA	4.02x
EV/FCF	4.25x
EV/Sales	2.25x
FCF yield	17.36%
Forward P/E	11.31x
P/B ratio	1.49x
P/E ratio	12.7x
P/S ratio	3.35x
PE Ratio10 Y	23.22x
PE Ratio3 Y	13.94x
PE Ratio5 Y	15.76x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	50.01%
EBITDA Margin	53.46%
FCF margin	58.21%
Gross margin	83.69%
Gross Profit	CNY 1.7B
Gross Profit Growth	-7.29%
Gross Profit Growth Q	-36.55%
Gross Profit Growth3 Y	-2.51%
Gross Profit Growth5 Y	6.78%
Net Income	CNY 463.3M
Net Income Growth	-12.47%
Net Income Growth Q	-39.36%
Net Income Growth Years	1%
Net Income Growth3 Y	-4.66%
Net Income Growth5 Y	5.76%
Pretax Margin	51.65%
Profit Margin	22.89%
Profit Per Employee	CNY 263,395
Profitable Years	25
ROA	12.52
Roa5y	14.74
ROCE	21.74
ROE	20.24
Roe5y	24.28
ROIC	73.63
Roic5y	71.97

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	3.89%
Cagr15y	6.67%
Cagr1y	2.28%
Cagr20y	16.69%
Cagr3y	-0.91%
Cagr5y	4.84%
Div CAGR10	41.64%
Div CAGR3	46.2%
Div CAGR5	48.17%
EPS Growth	-12.77
EPS Growth Q	-39.74
EPS Growth Years	1
EPS Growth3 Y	-4.74
EPS Growth5 Y	5.61
FCF Growth	66.6%
FCF Growth3 Y	0.27%
FCF Growth5 Y	11.22%
OCF Growth	63.97%
OCF Growth Q	-64.81%
OCF Growth10 Y	13.74%
OCF Growth3 Y	-0.51%
OCF Growth5 Y	9.73%
Revenue Growth	-7.1x
Revenue Growth Q	-33.11x
Revenue Growth Years	1x
Revenue Growth3 Y	-4.12x
Revenue Growth5 Y	0.38x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CNY 0.4
Assets	CNY 5B
Cash	CNY 3.3B
Current Assets	CNY 3.6B
Current Liabilities	CNY 297.5M
Equity	CNY 4.6B
Liabilities	CNY 393.8M
Long Term Assets	CNY 1.4B
Long Term Liabilities	CNY 96.3M
Net Cash	CNY 3.3B
Net Cash By Market Cap	CNY 48.08
Net Cash Growth	4.45%
Net Debt EBITDA	CNY -3.01
Net Debt Equity	CNY -0.72
Net Debt FCF	CNY -2.77
Tangible Book Value	CNY 2.8B
Tangible Book Value Per Share	CNY 11.74
WACC	4.23

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	12.06
Inventory Turnover	3.81
Net Working Capital	CNY 28.9M
Quick ratio	11.55
Working Capital	CNY 3.3B
Working Capital Turnover	CNY 0.65

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.34%
Dividend Growth	0%
Dividend Growth Years	0%
Dividend per share	CNY 2.5
Dividend Years	13
Dividend Yield	8.63%
Last Dividend	CNY 0.5
Payout Frequency	Semi-Annual
Payout Ratio	126.44%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	46.47%
1Y total return	2.28%
200-day SMA	32.77
3Y total return	-2.71%
50-day SMA	31.35
50-day SMA vs 200-day SMA	50under200
5Y total return	26.63%
All Time High	59.1
All Time High Change	-51%
All Time High Date	2015-06-15
All Time Low	1.4
All Time Low Change	1,974.5%
All Time Low Date	2005-07-04
ATR	0.64
Beta	-0
Beta1y	0.11
Beta2y	0.31
Ch YTD	-12.35
High	29.57
High52	36.7
High52 Date	2025-08-04
High52ch	-21.09%
Low	28.77
Low52	28.01
Low52 Date	2026-04-28
Low52ch	3.39%
Ma50ch	-7.63%
Price vs 200-day SMA	-11.61%
RSI	36.66
RSI Monthly	43.94
RSI Weekly	34.09
Sharpe ratio	-0.06x
Sortino ratio	0.17
Total Return	8.29%
Tr YTD	-12.35
Tr15y	163.41%
Tr1m	-6.49%
Tr1w	0.63%
Tr3m	-9.87%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CNY 1B
Operating Income Growth	-14.79
Operating Income Growth Q	-41.36
Operating Income Growth3 Y	-3.62
Operating Income Growth5 Y	8.05
Operating margin	50.01

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	159,957,021%
Shares Insiders	9.74%
Shares Institutions	20.23%
Shares Out	234,331,485
Shares Qo Q	-0.2%
Shares Yo Y	0.34%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CNY 1.2B
Average Volume	4,009,719.35x
Bv Per Share	12.63
CAPEX	CNY -58.1M
Ch10y	13.23
Ch15y	101.3
Ch1m	-6.49
Ch1w	0.63
Ch1y	-5.51
Ch20y	1,575.9
Ch3m	-9.87
Ch3y	-18.42
Ch5y	2.26
Ch6m	-17.09
Change	0.52%
Change From Open	-1.26
Close	28.81
Days Gap	1.8
Depreciation Amortization	70,615,329
Dollar Volume	125,938,352
Earnings Date	2026-04-24
EBIT	CNY 1B
EBITDA	CNY 1.1B
EPS	CNY 1.97
F Score	5
FCF	CNY 1.2B
FCF EV Yield	23.51x
FCF Per Share	CNY 5.03
Financing CF	-1,090,241,186
Fiscal Year End	December
Founded	1,993
Goodwill	26,133,365
Graham Number	23.66709
Graham Upside	-18.28
Income Tax	CNY 153.4M
Investing CF	-58,274,769
Is Primary Listing	1
Last Earnings Date	2026-04-24
Last Report Date	2026-03-31
Last Split Date	2017-06-16
Last Split Type	Forward
Lynch Fair Value	CNY 11.35
Lynch Upside	-60.8
Ma150	32.48
Ma150ch	-10.84%
Ma20	30.12
Ma20ch	-3.86%
Net CF	87,906,020
Next Earnings Date	2026-07-07
Open	29.33
P FCF Ratio	5.76
P OCF Ratio	5.49
Payment Date	2025-10-17
Position In Range	23.75
Ppne	786,431,014
Price Date	2026-05-08
Price EBITDA	CNY 6.27
Ptbv Ratio	2.46
Relative Volume	1.12x
Revenue	2,024,363,604x
Tax By Revenue	7.58x
Tax Rate	14.67%
Tr20y	2,092.7%
Tr6m	-17.09%
Volume	4,348,700

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

SHE/000915 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+8.6%

$2.50 annual per share

Payout ratio

+126.4%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+48.2%

0 consecutive years of growth

Total shareholder yield

+8.3%

Dividend yield + buyback yield combined

Performance

SHE/000915 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SHE/000915?

Insider, institutional, and short-interest positioning.

Institutional ownership

+20.2%

Share of float held by funds and institutions

Insider ownership

+9.7%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.3%

Negative means the company is buying back shares.

Technical

SHE/000915 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

36.7

Neutral momentum band

Price vs 200-day MA

-11.6%

50/200-day relationship not available

Beta (5Y)

-0.00

Less volatile than the market

Sharpe ratio

-0.06

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SHE/000915

Hub-level FAQ points readers to the deeper analysis pages.

What is the current she/000915 stock rating?

she/000915 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full she/000915 analysis?

The full report lives at /stocks/she/000915/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for she/000915?

The latest report frames she/000915 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the she/000915 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.